Immune checkpoint inhibitor efficacy against glioblastoma may decrease with dexamethasone

(American Association for Cancer Research) Among patients with glioblastoma receiving an immune checkpoint inhibitor, those who received the corticosteroid dexamethasone at baseline for cerebral edema had significantly worse overall survival.